Elke S. Perloff

965 total citations
13 papers, 618 citations indexed

About

Elke S. Perloff is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Elke S. Perloff has authored 13 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Elke S. Perloff's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Chemistry and Chromatography (2 papers). Elke S. Perloff is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Chemistry and Chromatography (2 papers). Elke S. Perloff collaborates with scholars based in United States, Germany and Canada. Elke S. Perloff's co-authors include David J. Greenblatt, Lisa L. von Moltke, Paul R. Skolnik, Su Duan, Jerold S. Harmatz, Ivar Roots, Andreas Johne, Steffen Bauer, Ingrid Mai and Klemens Budde and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Elke S. Perloff

13 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elke S. Perloff United States 11 303 181 134 110 103 13 618
Elke Störmer Germany 17 491 1.6× 425 2.3× 257 1.9× 199 1.8× 199 1.9× 18 1.2k
Martine Lebot France 8 276 0.9× 202 1.1× 123 0.9× 95 0.9× 119 1.2× 10 660
L VONMOLTKE United States 5 347 1.1× 188 1.0× 123 0.9× 102 0.9× 27 0.3× 9 551
Edmund Jon Deoon Lee Singapore 14 210 0.7× 161 0.9× 66 0.5× 91 0.8× 105 1.0× 25 731
Ayako Ohnishi Japan 8 223 0.7× 250 1.4× 95 0.7× 101 0.9× 19 0.2× 9 484
Yuichi Uwai Japan 18 263 0.9× 634 3.5× 416 3.1× 130 1.2× 19 0.2× 52 1.2k
Shuhuai Duan United States 4 459 1.5× 204 1.1× 118 0.9× 123 1.1× 11 0.1× 7 648
R Temple United States 4 261 0.9× 192 1.1× 114 0.9× 64 0.6× 28 0.3× 5 554
In‐June Cha South Korea 15 414 1.4× 243 1.3× 109 0.8× 164 1.5× 22 0.2× 25 822

Countries citing papers authored by Elke S. Perloff

Since Specialization
Citations

This map shows the geographic impact of Elke S. Perloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke S. Perloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke S. Perloff more than expected).

Fields of papers citing papers by Elke S. Perloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke S. Perloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke S. Perloff. The network helps show where Elke S. Perloff may publish in the future.

Co-authorship network of co-authors of Elke S. Perloff

This figure shows the co-authorship network connecting the top 25 collaborators of Elke S. Perloff. A scholar is included among the top collaborators of Elke S. Perloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke S. Perloff. Elke S. Perloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Stresser, David M., et al.. (2016). Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole. Drug Metabolism and Disposition. 44(8). 1424–1430. 19 indexed citations
3.
Huie, Keith, et al.. (2012). Loxapine P-glycoprotein Interactions In Vitro. Drug Metabolism Letters. 6(1). 26–32. 5 indexed citations
4.
Stresser, David M., et al.. (2009). Differential Time- and NADPH-Dependent Inhibition of CYP2C19 by Enantiomers of Fluoxetine. Drug Metabolism and Disposition. 37(4). 695–698. 16 indexed citations
5.
Perloff, Elke S., et al.. (2009). Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50shift approach facilitateskinactassay design. Xenobiotica. 39(2). 99–112. 71 indexed citations
6.
Preskorn, Sheldon, David J. Greenblatt, David A. Flockhart, et al.. (2007). Comparison of Duloxetine, Escitalopram, and Sertraline Effects on Cytochrome P450 2D6 Function in Healthy Volunteers. Journal of Clinical Psychopharmacology. 27(1). 28–34. 65 indexed citations
7.
Greenblatt, David J., Lisa L. von Moltke, Yan Luo, et al.. (2006). Ginkgo biloba Does Not Alter Clearance of Flurbiprofen, a Cytochrome P450‐2C9 Substrate. The Journal of Clinical Pharmacology. 46(2). 214–221. 48 indexed citations
8.
Greenblatt, D J, L VONMOLTKE, Elke S. Perloff, et al.. (2006). Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies. Clinical Pharmacology & Therapeutics. 79(1). 125–133. 78 indexed citations
9.
Perloff, Elke S., Su Duan, Paul R. Skolnik, David J. Greenblatt, & Lisa L. von Moltke. (2005). ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO. Drug Metabolism and Disposition. 33(6). 764–770. 123 indexed citations
10.
Greenblatt, D J, L VONMOLTKE, Elke S. Perloff, et al.. (2005). Effect of Ginkgo on CYP2C9: In vitro and in vivo studies. Clinical Pharmacology & Therapeutics. 77(2). P48–P48. 3 indexed citations
11.
Mai, Ingrid, Steffen Bauer, Elke S. Perloff, et al.. (2004). Hyperforin content determines the magnitude of the St John's wort–cyclosporine drug interaction. Clinical Pharmacology & Therapeutics. 76(4). 330–340. 102 indexed citations
12.
Mai, Ingrid, Elke S. Perloff, Steffen Bauer, et al.. (2004). MDR1 haplotypes derived from exons 21 and 26 do not affect the steady‐state pharmacokinetics of tacrolimus in renal transplant patients. British Journal of Clinical Pharmacology. 58(5). 548–553. 65 indexed citations
13.
Johne, Andreas, Elke S. Perloff, Steffen Bauer, et al.. (2004). Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. European Journal of Clinical Pharmacology. 60(9). 617–622. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elke Störmer Breakdown of academic impact, for papers by Martine Lebot Breakdown of academic impact, for papers by L VONMOLTKE Breakdown of academic impact, for papers by Edmund Jon Deoon Lee Breakdown of academic impact, for papers by Ayako Ohnishi Breakdown of academic impact, for papers by Yuichi Uwai Breakdown of academic impact, for papers by Shuhuai Duan Breakdown of academic impact, for papers by R Temple Breakdown of academic impact, for papers by In‐June Cha
Rankless by CCL
2026